Your browser is no longer supported. Please, upgrade your browser.
Settings
CBPO China Biologic Products, Inc. daily Stock Chart
CBPO [NASD]
China Biologic Products, Inc.
Index- P/E31.69 EPS (ttm)3.73 Insider Own1.70% Shs Outstand26.98M Perf Week2.68%
Market Cap3.19B Forward P/E19.29 EPS next Y6.13 Insider Trans-22.95% Shs Float23.20M Perf Month18.66%
Income101.80M PEG1.98 EPS next Q1.24 Inst Own75.60% Short Float7.17% Perf Quarter3.67%
Sales341.20M P/S9.35 EPS this Y14.10% Inst Trans-0.35% Short Ratio7.80 Perf Half Y2.87%
Book/sh17.02 P/B6.95 EPS next Y19.52% ROA16.70% Target Price136.60 Perf Year-0.85%
Cash/sh6.81 P/C17.35 EPS next 5Y16.00% ROE22.70% 52W Range96.99 - 137.38 Perf YTD9.95%
Dividend- P/FCF44.12 EPS past 5Y40.50% ROI25.70% 52W High-14.06% Beta1.71
Dividend %- Quick Ratio3.20 Sales past 5Y17.40% Gross Margin63.60% 52W Low21.74% ATR2.47
Employees1799 Current Ratio5.40 Sales Q/Q13.60% Oper. Margin42.10% RSI (14)80.91 Volatility2.47% 2.25%
OptionableYes Debt/Eq0.00 EPS Q/Q15.60% Profit Margin29.80% Rel Volume0.46 Prev Close118.22
ShortableYes LT Debt/Eq0.00 EarningsMay 03 AMC Payout0.00% Avg Volume213.35K Price118.07
Recom1.70 SMA208.77% SMA5012.63% SMA2003.90% Volume92,698 Change-0.12%
Mar-01-16Downgrade Credit Suisse Outperform → Neutral
Oct-08-15Initiated Credit Suisse Outperform
Jul-09-15Initiated BofA/Merrill Buy $135
Jul-08-14Reiterated Aegis Capital Buy $50 → $55
Mar-14-14Initiated Oppenheimer Outperform $46
Nov-06-13Downgrade Aegis Capital Buy → Hold
Mar-14-13Reiterated Aegis Capital Buy $22 → $28
May-13-10Reiterated Brean Murray Buy $19 → $20
Mar-26-10Reiterated Brean Murray Buy $15 → $19
Apr-21-17 08:00AM  China Biologic Products to Report First Quarter of 2017 Financial Results PR Newswire
Apr-12-17 01:21PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : April 12, 2017 Capital Cube
Apr-11-17 08:17AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : April 11, 2017 Capital Cube
Apr-07-17 04:05PM  ETFs with exposure to China Biologic Products, Inc. : April 7, 2017 Capital Cube
Mar-02-17 10:06AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Capital Cube
10:06AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017
Mar-01-17 01:04PM  CHINA BIOLOGIC PRODUCTS, INC. Financials
Feb-24-17 01:22PM  Edited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT Thomson Reuters StreetEvents
Feb-23-17 07:53PM  China Biologic Products posts 4Q profit Associated Press
05:00PM  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 PR Newswire
04:57PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-K, Annual Report
07:07AM  Q4 2016 China Biologic Products Inc Earnings Release - After Market Close
Feb-14-17 04:05PM  China Biologic Products to Report Fourth Quarter and Fiscal Year 2016 Financial Results PR Newswire
Jan-30-17 09:20AM  New Strong Sell Stocks for January 30th Zacks
Jan-27-17 01:34PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : January 27, 2017 Capital Cube
01:34PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : January 27, 2017
Jan-26-17 07:52AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : January 26, 2017 Capital Cube
07:52AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : January 26, 2017
Jan-18-17 08:01AM  New Strong Sell Stocks for January 18th
Jan-06-17 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  China Biologic to Build New Collection Station and New Branch Collection Facility in Shandong Province PR Newswire
Jan-04-17 08:47AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:30AM  China Biologic to Attend the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-01-17 07:22AM  3 Biotech Stocks That Turned $10,000 Into Over $100,000 at Motley Fool
Dec-14-16 12:49PM  ETFs with exposure to China Biologic Products, Inc. : December 14, 2016
Dec-01-16 01:16PM  Should You Follow Hedge Funds Into China Biologic Products Inc (CBPO)? at Insider Monkey -5.12%
10:52AM  ETFs with exposure to China Biologic Products, Inc. : December 1, 2016
Nov-30-16 07:12AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : November 30, 2016
Nov-18-16 11:02AM  Should You Be Bullish on Tata Motors Limited (ADR) (TTM), China Biologic Products Inc (CBPO), & Two More? at Insider Monkey
Nov-08-16 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events
Nov-07-16 09:52AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
07:16AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : November 7, 2016
Nov-03-16 12:12PM  Edited Transcript of CBPO earnings conference call or presentation 3-Nov-16 11:30am GMT
05:07AM  China Biologic Products posts 3Q profit
Nov-02-16 05:00PM  China Biologic Reports Financial Results for the Third Quarter of 2016 PR Newswire
04:07PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
07:07AM  Q3 2016 China Biologic Products Inc Earnings Release - After Market Close
Oct-31-16 08:34AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events
Oct-27-16 08:15AM  Blog Coverage China Biologic Takes Full Ownership of Guizhou Taibang Accesswire
08:09AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : October 27, 2016
Oct-26-16 08:30AM  China Biologic Acquires Full Ownership of Guizhou Taibang PR Newswire
Oct-24-16 04:15PM  China Biologic Products to Report Third Quarter 2016 Financial Results PR Newswire
Oct-12-16 08:47AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 12, 2016
Oct-11-16 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III PR Newswire
Sep-20-16 08:38AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Sep-19-16 08:30AM  China Biologic Receives CFDA Clinical Trial Approval for Human Coagulation Factor IX PR Newswire
Sep-08-16 10:53AM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : September 8, 2016
Sep-07-16 08:10AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : September 7, 2016
Sep-06-16 10:09AM  ETFs with exposure to China Biologic Products, Inc. : September 6, 2016 +7.02%
Aug-31-16 06:51PM  Soros, Harvard Make Opposite Bets on China Plasma Company: Chart at Bloomberg
Aug-25-16 10:07AM  ETFs with exposure to China Biologic Products, Inc. : August 25, 2016
Aug-24-16 08:16AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : August 24, 2016
Aug-17-16 11:48AM  Massive Insider Selling at Northrop Grumman (NOC) and Chinese Biotech, While Insider Buying Observed at 3 Other Companies at Insider Monkey
Aug-16-16 08:31AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
Aug-15-16 08:30AM  China Biologic Announces Change to Board of Directors PR Newswire
Aug-11-16 07:26AM  Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio
Aug-08-16 04:09PM  China Biologic Products, Inc.: Leads amongst peers with strong fundamentals -5.36%
12:25PM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016
Aug-05-16 12:08PM  Edited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT +10.46%
06:48AM  China Biologic Products posts 2Q profit
Aug-04-16 05:17PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a
05:00PM  China Biologic Reports Financial Results for the Second Quarter of 2016 PR Newswire
04:34PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q2 2016 China Biologic Products Inc Earnings Release - After Market Close
Jul-29-16 10:02PM  SSE Composite Index Fell amid Rumors of Stricter Rules to Curb WMPs
Jul-22-16 08:30AM  China Biologic Products to Report Second Quarter 2016 Financial Results PR Newswire
Jul-18-16 08:21AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : July 18, 2016
Jul-08-16 08:08AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : July 8, 2016
Jul-04-16 09:36AM  Can You Expect Monetary Easing in China post-Brexit?
Jul-01-16 06:01PM  ETFs with exposure to China Biologic Products, Inc. : July 1, 2016
Jun-28-16 09:09AM  IMF Provides a Positive Assessment of Chinas Economy
Jun-20-16 02:09PM  ETFs with exposure to China Biologic Products, Inc. : June 20, 2016
08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events,
08:30AM  China Biologic Opens Plasma Collection Station in Hebei Province PR Newswire
Jun-13-16 08:01AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure -5.37%
Jun-07-16 08:07AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : June 7, 2016
Jun-06-16 04:33PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
Jun-02-16 04:53PM  China Biologic Announces Secondary Offering of Common Stock PR Newswire
May-31-16 11:28AM  Macro Factors to Look for When Investing in China
May-23-16 04:54PM  ETFs with exposure to China Biologic Products, Inc. : May 23, 2016
May-10-16 10:48AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q1, 2016 By the Numbers
08:22AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : May 10, 2016
May-05-16 11:31AM  Edited Transcript of CBPO earnings conference call or presentation 5-May-16 11:30am GMT
12:01AM  [$$] China Biologic Is Out For Blood and Lots of It at Barrons.com
May-04-16 05:31PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
05:00PM  China Biologic Reports Financial Results for the First Quarter of 2016 PR Newswire
04:58PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q1 2016 China Biologic Products Inc Earnings Release - After Market Close
May-02-16 05:00PM  China's Blood Shortages Pump New Life Into $16 Billion Drugmaker at Bloomberg
Apr-22-16 08:30AM  China Biologic Products to Report First Quarter 2016 Financial Results PR Newswire
Apr-07-16 07:38PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : April 7, 2016
Apr-06-16 08:11AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : April 6, 2016 +7.47%
Mar-31-16 11:23AM  ETFs with exposure to China Biologic Products, Inc. : March 31, 2016
Mar-15-16 09:04PM  China-Focused Mutual Funds: For Long-Term Adventurous Investors
Mar-08-16 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure
Mar-07-16 04:56PM  Why FEAAX Could Be on Your Shortlist
Mar-04-16 04:59PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
04:54PM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-03-16 10:07AM  OBCHX: Exposure to Small to Mid-Size Companies
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and immunoglobulin for intravenous injection products for original and secondary immunoglobulin deficiency, and auto-immune deficiency diseases; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing human hepatitis B immunoglobulin (pH4) for intravenous injection; human fibrinogen; immune globulin intravenous; human antithrombin III; human cytomegalovirus immunoglobulin; human coagulation factor IX; and human fibrin sealant products. The company sells its products directly, as well as through distributors. China Biologic Products, Inc. is headquartered in Beijing, the People's Republic of China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shao SeanDirectorMar 02Sale100.8016,0001,612,80020,000Mar 03 04:32 PM
Shao SeanDirectorMar 01Sale100.704,000402,80036,000Mar 03 04:32 PM
Gao DavidChief Executive OfficerMar 01Sale100.5754,0495,435,708395,347Mar 02 04:30 PM
Gao DavidChief Executive OfficerFeb 28Sale100.6962,6046,303,597449,396Mar 02 04:30 PM
Yeung AlbertDirectorDec 09Option Exercise10.4325,000260,65045,000Dec 12 06:50 AM
Yang MingChief Financial OfficerAug 15Sale124.3221,0922,622,15724,782Aug 17 07:47 AM
Yin MingSr. Corporate Vice PresidentAug 15Sale124.3220,3342,527,92316,467Aug 17 07:42 AM
Yang Gang CBPOCorporate Vice PresidentAug 15Sale124.328,4001,044,28832,242Aug 17 07:39 AM
Liu Zhijing CBPOCorporate Vice PresidentAug 15Sale124.321,968244,6620Aug 17 07:30 AM
Liu WenfangDirectorAug 15Sale124.322,900360,5283,383Aug 17 07:21 AM
WP X Biologics LLCDirectorJun 08Sale111.002,775,000308,025,0001,312,200Jun 08 07:13 PM
WP X Biologics LLCDirectorJun 08Sale111.002,775,000308,025,0001,312,200Jun 08 07:09 PM
Fang MinDirectorJun 08Sale111.002,775,000308,025,0001,312,200Jun 08 07:04 PM
Yin MingSenior Corporate VPMay 20Sale113.408,645980,34331,801May 23 04:36 PM
Yang Gang CBPOCorporate Vice PresidentMay 20Sale113.4011,7051,327,34735,642May 23 04:36 PM
Yin MingSenior Corporate VPMay 19Sale113.8310,9731,249,05740,446May 23 04:36 PM
Yang Gang CBPOCorporate Vice PresidentMay 19Sale113.8314,8581,691,28647,347May 23 04:36 PM
Yin MingSenior Corporate VPMay 16Option Exercise12.2630,000367,80051,419May 23 04:36 PM
Yang Gang CBPOCorporate Vice PresidentMay 16Option Exercise12.2640,000490,40062,205May 23 04:36 PM